ELV Stock Overview
Operates as a health benefits company in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for ELV from our risk checks.
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
Elevance Health, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$373.30 |
| 52 Week High | US$513.40 |
| 52 Week Low | US$348.00 |
| Beta | 0.84 |
| 1 Month Change | 1.14% |
| 3 Month Change | -1.56% |
| 1 Year Change | -21.58% |
| 3 Year Change | -6.63% |
| 5 Year Change | 37.27% |
| Change since IPO | 52.13% |
Recent News & Updates
Recent updates
Shareholder Returns
| ELV | AT Healthcare | AT Market | |
|---|---|---|---|
| 7D | -1.4% | -0.3% | 4.0% |
| 1Y | -21.6% | 13.1% | 13.4% |
Return vs Industry: ELV underperformed the Austrian Healthcare industry which returned 13.1% over the past year.
Return vs Market: ELV underperformed the Austrian Market which returned 13.4% over the past year.
Price Volatility
| ELV volatility | |
|---|---|
| ELV Average Weekly Movement | 3.5% |
| Healthcare Industry Average Movement | 4.8% |
| Market Average Movement | 3.8% |
| 10% most volatile stocks in AT Market | 5.7% |
| 10% least volatile stocks in AT Market | 1.9% |
Stable Share Price: ELV has not had significant price volatility in the past 3 months compared to the Austrian market.
Volatility Over Time: ELV's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 104,900 | Gail Boudreaux | www.elevancehealth.com |
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
Elevance Health, Inc. Fundamentals Summary
| ELV fundamental statistics | |
|---|---|
| Market cap | €86.03b |
| Earnings (TTM) | €5.70b |
| Revenue (TTM) | €168.50b |
15.1x
P/E Ratio0.5x
P/S RatioIs ELV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ELV income statement (TTM) | |
|---|---|
| Revenue | US$176.81b |
| Cost of Revenue | US$127.57b |
| Gross Profit | US$49.24b |
| Other Expenses | US$43.26b |
| Earnings | US$5.98b |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 25.78 |
| Gross Margin | 27.85% |
| Net Profit Margin | 3.38% |
| Debt/Equity Ratio | 75.4% |
How did ELV perform over the long term?
See historical performance and comparisonDividends
1.8%
Current Dividend Yield25%
Payout RatioDoes ELV pay a reliable dividends?
See ELV dividend history and benchmarks| Elevance Health dividend dates | |
|---|---|
| Ex Dividend Date | Mar 10 2025 |
| Dividend Pay Date | Mar 25 2025 |
| Days until Ex dividend | 21 days |
| Days until Dividend pay date | 36 days |
Does ELV pay a reliable dividends?
See ELV dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/15 12:15 |
| End of Day Share Price | 2025/02/14 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Elevance Health, Inc. is covered by 48 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jasper Hellweg | Argus Research Company |
| Hua Ha | Baird |
| Ishan Majumdar | Baptista Research |